Genomic evolution from hormonal therapies and suitability of prostate cancer diagnostic specimens for metastatic prostate cancer (mPC) genomic stratification.

Authors

null

Amado J. Zurita

The University of Texas MD Anderson Cancer Center, Houston, TX

Amado J. Zurita , Ryon Graf , Guillermo Villacampa , Kira Raskina , Ethan Sokol , Dexter X. Jin , Richard S.P. Huang , Irene Casanova Salas , Joan Carles , Jeffrey S. Ross , Alexa Betzig Schrock , Geoffrey R. Oxnard , Joaquin Mateo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 143)

DOI

10.1200/JCO.2022.40.6_suppl.143

Abstract #

143

Poster Bd #

H4

Abstract Disclosures